Dr. Harbeck discusses the plasminogen activator system and its role in tumor invasion and metastasis in solid tumors and the factors that may influence treatment decisions, as well as its utility as a therapy target at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics.
Link to this comment:
All Comments (0)